Astrid Helene Livbjerg

Aalborg University Hospital

Papers

1

Total Citations

5

H-Index

1

About

Astrid Helene Livbjerg is a leading clinical researcher in urologic oncology, with a focused expertise in robotic-assisted radical cystectomy and urinary diversion techniques. Her work centers on improving surgical outcomes for bladder cancer patients, particularly by reducing the incidence of benign ureteroenteric strictures—a common and debilitating complication following bladder removal. Livbjerg is the principal investigator of the landmark DaBlaCa-16 MOSAIC randomized controlled trial, which introduced the retrosigmoid ileal conduit as a novel approach to lower left-sided ureteral stricture rates. Her 2024 feasibility study on this technique, already garnering 5 citations in its first year, demonstrates her capacity to drive practice-changing surgical innovation. By addressing a specific anatomical challenge through rigorous trial design, Livbjerg is shaping the next generation of reconstructive urology. Her work not only advances technical precision in robot-assisted surgery but also directly enhances patient quality of life, marking her as a rising authority in evidence-based urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial—Feasibility and 90-day Postoperative Complications
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Aalborg University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago